IKZF1 and autoimmune disease: Similarly, coding mutations of IKZF1 in humans mainly present with hypogammaglobulinaemia, while only a subset of patients develop autoimmunity.43–46 Overall, this suggests that Ikaros acts as a complex modulator of B cell activation and therefore represents a valuable target in autoimmune diseases.